Pascal Krotee
Analista di Private Equity presso RiverVest Venture Management LLC
Profilo
Pascal joined the RiverVest team as Senior Associate in 2021.
In this role, she focuses on sourcing and completing due diligence on prospective portfolio companies in both the therapeutics and medical devices sectors.
She serves as an observer at Bluejay Therapeutics, Avalyn Pharmaceuticals, and Biolinq.
She also supports the operational activities of RiverVest’s portfolio companies.
Prior to joining the team, Pascal spent nearly 4 years as an Investment Associate at Kairos Ventures, where she focused on investments in the life sciences.
While at Kairos, she sourced new opportunities for investment, led due diligence, and served on the Board of Directors of several portfolio companies.
Like many on the RiverVest team, Pascal is a scientist by training.
She earned a Ph.D.
in Molecular Biology at UCLA, where she studied the atomic structures of proteins associated with Alzheimer’s disease and type-II diabetes and worked to create compounds that inhibited these structures.
Prior to graduate school, Pascal worked as Junior Specialist at the Development Biology Center at UC Irvine.
She earned a B.S.
in Developmental and Cell Biology with a Minor in Business Management from UC Irvine.
Posizioni attive di Pascal Krotee
Società | Posizione | Inizio |
---|---|---|
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri. | Analista di Private Equity | 01/01/2021 |
Precedenti posizioni note di Pascal Krotee
Società | Posizione | Fine |
---|---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Investitore di Private Equity | 28/02/2021 |
Holoclara, Inc.
Holoclara, Inc. Pharmaceuticals: MajorHealth Technology Holoclara, Inc. develops immunotherapy drugs to autoimmune disorders. The company was founded by Andrea Choe in March 2017 and is headquartered in Pasadena, CA. | Direttore/Membro del Consiglio | 28/02/2021 |
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Direttore/Membro del Consiglio | 28/02/2021 |
Formazione di Pascal Krotee
University of California | Doctorate Degree |
University of California Irvine School of Medicine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri. | Finance |
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Finance |
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Health Technology |
Holoclara, Inc.
Holoclara, Inc. Pharmaceuticals: MajorHealth Technology Holoclara, Inc. develops immunotherapy drugs to autoimmune disorders. The company was founded by Andrea Choe in March 2017 and is headquartered in Pasadena, CA. | Health Technology |
- Borsa valori
- Insiders
- Pascal Krotee